Conv. Plasma
Nigella Sativa

Home COVID-19 treatment researchSleepSleep (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

Summary of COVID-19 sleep studies

Studies   Meta Analysis   Hide extended summaries

46,535 patient sleep study: 43% lower mortality (p=0.02) and 36% lower hospitalization (p=0.008).
UK Biobank retrospective, 46,535 participants with sleep behavior assessed between 2006 and 2010, showing higher risk of hospitalization and mortality with poor sleep.

Jun 2021, Sleep,,

136 patient sleep study: 81% lower severe cases (p=0.02).
Retrospective 164 COVID-19 patients and 188 controls in China, showing the risk of severe cases associated with lack of sleep.

Nov 2021, Nature and Science of Sleep,,

sleep study: 39% lower mortality (p=0.001), 32% lower hospitalization (p<0.0001), and 7% fewer cases (p=0.04).
FinnGen Mendelian randomization study showing higher risk of COVID-19 mortality, hospitalization, and infection with insomnia.

Jul 2022, Sleep Medicine,,

5,197 patient sleep study: 40% fewer cases (p=0.01).
Retrospective 5,197 Greek adults over 65. After adjustment for confounders, COVID-19 infection was independently associated with poor sleep, low physical activity, low Mediterranean diet adherence, living in urban areas, smoking, obesity, depression, anxiety, stress, and poor health-related quality of life.

Nov 2023, Diseases,,

1,811 patient sleep study: 67% lower PASC (p<0.0001).
Retrospective 1,811 COVID-19 patients in the UK, showing lower risk of self-reported long COVID with good sleep quality in the month before infection.

Apr 2022, medRxiv,,

1,979 patient sleep study: 36% lower PASC (p=0.0004).
Retrospective 1,979 nurses in the USA, showing lower risk of long COVID with better sleep quality.

May 2023, JAMA Network Open,,

1,500 patient sleep study: 38% lower severe cases (p<0.0001).
Retrospective 1,500 COVID+ patients in Bangladesh, showing lower risk of severe cases with good sleep.

Sep 2021, Infection and Drug Resistance,,

2,884 patient sleep study: 17% fewer moderate/severe cases (p=0.03) and 11% fewer cases (p=0.003).
Retrospective 2,884 high-risk healthcare workers in France, Germany, Italy, Spain, UK, and the USA, showing shorter sleep duration associated with increased risk of COVID-19 cases and severity.

Mar 2021, BMJ Nutrition, Prevention & Health,,

315 patient sleep study: 36% fewer cases (p=0.04).
Case control study in China with 105 cases and 210 matched controls, showing COVID-19 cases associated with lack of sleep.

Nov 2020, PLOS ONE,,

68,896 patient sleep study: 19% lower mortality (p=0.0008), 15% lower hospitalization (p<0.0001), and 23% lower PASC (p<0.0001).
Prospective study of 68,896 UK Biobank participants with COVID-19 showing adherence to a healthy lifestyle prior to infection, characterized by 10 factors including adequate physical activity and sleep, not smoking, and a healthy BMI, was associated with a significantly lower risk of mortality, hospitalization, and post-COVID multisystem sequelae. Risk decreased monotonically for increasing numbers of healthy lifestyle factors from 5-10. Reduced risks were evident across cardiovascular, metabolic, neurologic, respiratory, and other disorders over 210 days following infection, during both acute and post-acute phases, regardless of age, sex, ethnicity, test setting, vaccination status, or SARS-CoV-2 variant.

Jan 2024, medRxiv,,

14,335 patient sleep study: 16% fewer symptomatic cases (p=0.0007).
Prospective survey based study with 14,335 participants, showing risk of viral symptoms associated with shorter sleep duration.

Jun 2021, PLOS ONE,,

2,586 patient sleep study: 32% fewer symptomatic cases (p=0.09).
Analysis of 2,586 participants of a running injury prevention RCT in the Netherlands, showing higher risk of COVID-19 symptoms with sleep disturbance.

Oct 2020, J. Science and Medicine in Sport,,

1,847 patient sleep study: 17% fewer moderate/severe cases (p=0.06) and 7% lower PASC (p=0.51).
Retrospective 1,847 COVID+ patients in Poland, showing lower moderate/severe cases with improved sleep, without statistical significance. Hospitalized patients were excluded.

Oct 2022, Frontiers in Medicine,,

15,227 patient sleep study: 12% fewer cases (p=0.5).
Prospective survey-based study with 15,227 people in the UK, showing reduced risk of COVID-19 cases with 8 hours sleep, with statistical significance when compared with ≥9 hours. NCT04330599. COVIDENCE UK.

Mar 2021, Thorax,,

468,569 patient sleep study: 3% lower mortality (p=0.91).
Retrospective 468,569 adults in the UK, showing no significant difference in COVID-19 mortality based on sleep quality.

Aug 2021, Brain, Behavior, and Immunity,,
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Thanks for your feedback! Please search before submitting papers and note that studies are listed under the date they were first available, which may be the date of an earlier preprint.